{"pmid":32365221,"title":"Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19.","text":["Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19.","BACKGROUND: Effective laboratory markers for estimation of disease severity and predicting the clinical progression of coronavirus disease-2019 (COVID-19) is urgent needed. METHODS: The laboratory tests including blood routine, cytokine profiles and infection markers were collected from 389 confirmed COVID-19 patients. RESULTS: The included patients were classified into mild (n=168), severe (n=169) and critical groups (n=52). The leukocytes, neutrophils, infection biomarkers (such as CRP, PCT and ferritin) and the concentrations of cytokines (IL-2R, IL-6, IL-8, IL-10 and TNF-alpha) were significantly increased while lymphocytes were significantly decreased with increased severity of illness. The amounts of IL-2R was positively correlated with the other cytokines and negatively correlated with lymphocyte number. The ratio of IL-2R to lymphocytes was found remarkably increased in severe and critical patients. IL-2R/lymphocyte was superior compared with other markers for the identification of COVID-19 with critical illness not only from mild but also from severe illness. Moreover, the cytokine profiles and IL-2R/lymphocyte were significantly decreased in recovered patients but further increased in disease deteriorated patients, which might be correlated with the outcome of COVID-19. CONCLUSIONS: Lymphopenia and increased levels of cytokines were closely associated with the disease severity. IL-2R/lymphocyte was a prominent biomarker for early identification of severe COVID-19 and predicting the clinical progression of the disease.","Clin Exp Immunol","Hou, Hongyan","Zhang, Bo","Huang, Hui","Luo, Ying","Wu, Shiji","Tang, Guoxing","Liu, Weiyong","Mao, Lie","Mao, Liyan","Wang, Feng","Sun, Ziyong","32365221"],"abstract":["BACKGROUND: Effective laboratory markers for estimation of disease severity and predicting the clinical progression of coronavirus disease-2019 (COVID-19) is urgent needed. METHODS: The laboratory tests including blood routine, cytokine profiles and infection markers were collected from 389 confirmed COVID-19 patients. RESULTS: The included patients were classified into mild (n=168), severe (n=169) and critical groups (n=52). The leukocytes, neutrophils, infection biomarkers (such as CRP, PCT and ferritin) and the concentrations of cytokines (IL-2R, IL-6, IL-8, IL-10 and TNF-alpha) were significantly increased while lymphocytes were significantly decreased with increased severity of illness. The amounts of IL-2R was positively correlated with the other cytokines and negatively correlated with lymphocyte number. The ratio of IL-2R to lymphocytes was found remarkably increased in severe and critical patients. IL-2R/lymphocyte was superior compared with other markers for the identification of COVID-19 with critical illness not only from mild but also from severe illness. Moreover, the cytokine profiles and IL-2R/lymphocyte were significantly decreased in recovered patients but further increased in disease deteriorated patients, which might be correlated with the outcome of COVID-19. CONCLUSIONS: Lymphopenia and increased levels of cytokines were closely associated with the disease severity. IL-2R/lymphocyte was a prominent biomarker for early identification of severe COVID-19 and predicting the clinical progression of the disease."],"journal":"Clin Exp Immunol","authors":["Hou, Hongyan","Zhang, Bo","Huang, Hui","Luo, Ying","Wu, Shiji","Tang, Guoxing","Liu, Weiyong","Mao, Lie","Mao, Liyan","Wang, Feng","Sun, Ziyong"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365221","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/cei.13450","keywords":["covid-19","il-2r/lymphocyte ratio","sars-cov-2","clinical progression","cytokine"],"locations":["Lymphopenia"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138496044105728,"score":9.490897,"similar":[{"pmid":32470153,"title":"Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.","text":["Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.","OBJECTIVE: To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe COVID-19. METHODS: A total of 27 patients with severe COVID-19 who were admitted to Tongji Hospital in Wuhan from 1 to 21 February 2020 were recruited to the study. The characteristics of interleukin (IL)-1beta, IL-2 receptor (IL-2R), IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP), serum ferritin and procalcitonin (PCT), and lymphocyte subsets of these patients were retrospectively compared before and after treatment. RESULTS: Before treatment, there was no significant difference in most inflammatory factors (IL-1beta, IL-2R, IL-6, IL-8, IL-10, CRP and serum ferritin) between male and female patients. Levels of IL-2R, IL-6, TNF-alpha and CRP decreased significantly after treatment, followed by IL-8, IL-10 and PCT. Serum Ferritin was increased in all patients before treatment, but did not decrease significantly after treatment. IL-1beta was normal in most patients before treatment. Lymphopenia was common among these patients with severe COVID-19. Analysis of lymphocyte subsets showed that CD4(+) and particularly CD8(+) T lymphocytes increased significantly after treatment. However, B lymphocytes and natural killer cells showed no significant changes after treatment. CONCLUSIONS: A pro-inflammatory response and decreased level of T lymphocytes were associated with severe COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Ni, Ming","Tian, Fang-Bing","Xiang, Dan-Dan","Yu, Bing","32470153"],"abstract":["OBJECTIVE: To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe COVID-19. METHODS: A total of 27 patients with severe COVID-19 who were admitted to Tongji Hospital in Wuhan from 1 to 21 February 2020 were recruited to the study. The characteristics of interleukin (IL)-1beta, IL-2 receptor (IL-2R), IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP), serum ferritin and procalcitonin (PCT), and lymphocyte subsets of these patients were retrospectively compared before and after treatment. RESULTS: Before treatment, there was no significant difference in most inflammatory factors (IL-1beta, IL-2R, IL-6, IL-8, IL-10, CRP and serum ferritin) between male and female patients. Levels of IL-2R, IL-6, TNF-alpha and CRP decreased significantly after treatment, followed by IL-8, IL-10 and PCT. Serum Ferritin was increased in all patients before treatment, but did not decrease significantly after treatment. IL-1beta was normal in most patients before treatment. Lymphopenia was common among these patients with severe COVID-19. Analysis of lymphocyte subsets showed that CD4(+) and particularly CD8(+) T lymphocytes increased significantly after treatment. However, B lymphocytes and natural killer cells showed no significant changes after treatment. CONCLUSIONS: A pro-inflammatory response and decreased level of T lymphocytes were associated with severe COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ni, Ming","Tian, Fang-Bing","Xiang, Dan-Dan","Yu, Bing"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470153","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26070","keywords":["covid-19","lymphopenia","pro-inflammatory","severe pneumonia"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668167110047563776,"score":580.20483},{"pmid":32026671,"title":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","text":["[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients.","Zhonghua Jie He He Hu Xi Za Zhi","Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S","32026671"],"abstract":["Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S"],"date":"2020-02-07T11:00:00Z","year":2020,"_id":"32026671","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.3760/cma.j.issn.1001-0939.2020.0005","keywords":["2019 novel coronavirus pneumonia","clinical features","disease severity","inflammatory cytokines"],"locations":["Tongji","Tongji"],"e_drugs":["Creatinine","Bilirubin"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138490890354688,"score":438.6286},{"pmid":32360479,"pmcid":"PMC7191272","title":"2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases.","text":["2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases.","OBJECTIVE: To analyze the diagnosis and treatment of patients with chronic renal failure complicated with novel coronavirus pneumonia, and to evaluate the effect of blood purification technology on the treatment and prognosis of such patients METHODS: Two COVID-19 cases undergoing hemodialysis with chronic renal failure were retrospectively analysed in our hospital. RESULTS: Two COVID-19 patients were admitted to hospital due to cough, with or without fever. Laboratory tests showed decreased lymphocyte count, elevated PCT, IL-10, IL-6, TNF-alpha, IL-2R, high-sensitivity cardiac troponin I, NT-proBNP, creatinine, and urea nitrogen. Chest CT scan showed multiple blurred plaques and patchy shadows in both patients. Two patients received continuous venovenous hemodiafiltration (CVVHDF) every other day for 4-6 hours everytime, in addition to the standard treatment. After CVVHDF, not only cytokines were reduced, but also liver function and cardiac function significantly improved. Both patients did not develop severe pneumonia. They were discharged on March 1, 2020 when meeting the discharge criteria. CONCLUSION: Two COVID-19 patients on maintenance hemodialysis discharged after a month of hospitalization. The removal of cytokines through blood purification technology may be beneficial for the recovery of COVID-19 patients.","Clin Biochem","Ke, Chunjin","Wang, Yufeng","Zeng, Xing","Yang, Chunguang","Hu, Zhiquan","32360479"],"abstract":["OBJECTIVE: To analyze the diagnosis and treatment of patients with chronic renal failure complicated with novel coronavirus pneumonia, and to evaluate the effect of blood purification technology on the treatment and prognosis of such patients METHODS: Two COVID-19 cases undergoing hemodialysis with chronic renal failure were retrospectively analysed in our hospital. RESULTS: Two COVID-19 patients were admitted to hospital due to cough, with or without fever. Laboratory tests showed decreased lymphocyte count, elevated PCT, IL-10, IL-6, TNF-alpha, IL-2R, high-sensitivity cardiac troponin I, NT-proBNP, creatinine, and urea nitrogen. Chest CT scan showed multiple blurred plaques and patchy shadows in both patients. Two patients received continuous venovenous hemodiafiltration (CVVHDF) every other day for 4-6 hours everytime, in addition to the standard treatment. After CVVHDF, not only cytokines were reduced, but also liver function and cardiac function significantly improved. Both patients did not develop severe pneumonia. They were discharged on March 1, 2020 when meeting the discharge criteria. CONCLUSION: Two COVID-19 patients on maintenance hemodialysis discharged after a month of hospitalization. The removal of cytokines through blood purification technology may be beneficial for the recovery of COVID-19 patients."],"journal":"Clin Biochem","authors":["Ke, Chunjin","Wang, Yufeng","Zeng, Xing","Yang, Chunguang","Hu, Zhiquan"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360479","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.clinbiochem.2020.04.008","keywords":["covid-19","cvvhdf","chronic renal failure","cytokine storm","hemodialysis","sars-cov-2"],"e_drugs":["Nitrogen","Creatinine","Urea"],"topics":["Case Report"],"weight":1,"_version_":1666138495513526272,"score":354.4261},{"pmid":32324595,"title":"The laboratory tests and host immunity of COVID-19 patients with different severity of illness.","text":["The laboratory tests and host immunity of COVID-19 patients with different severity of illness.","BACKGROUND: The Coronavirus Disease-2019 (COVID-19), infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a severe outbreak in China. The host immunity of COVID-19 patients is unknown. METHODS: The routine laboratory tests and host immunity in COVID-19 patients with different severity of illness were compared after patient admission. RESULTS: A total of 65 SARS-CoV-2-positive patients were classified as mild (n=30), severe (n=20), and extremely severe (n=15) illness. Many routine laboratory tests such as ferritin, lactate dehydrogenase and D-dimer were increased in severe and extremely severe patients. The absolute numbers of CD4+ T cells, CD8+ T cells and B cells were all gradually decreased with increased severity of illness. The activation markers such as HLA-DR and CD45RO expressed on CD4+ and CD8+ T cells were increased in severe and extremely severe patients compared with mild patients. The co-stimulatory molecule CD28 had opposite results. The percentage of natural regulatory T cells was decreased in extremely severe patients. The percentage of IFN-gamma producing CD8+ T cells was increased in both severe and extremely severe patients compared with mild patients. The percentage of IFN-gamma producing CD4+ T cells was increased in extremely severe patients. The IL-2R, IL-6, and IL-10 were all increased in extremely severe patients. The activation of DC and B cells was decreased in extremely severe patients. CONCLUSIONS: The number and function of T cells are inconsistent in COVID-19 patients. The hyperfunction of CD4+ and CD8+ T cells is associated with the pathogenesis of extremely severe SARS-CoV-2 infection.","JCI Insight","Wang, Feng","Hou, Hongyan","Luo, Ying","Tang, Guoxing","Wu, Shiji","Huang, Min","Liu, Weiyong","Zhu, Yaowu","Lin, Qun","Mao, Liyan","Fang, Minghao","Zhang, Huilan","Sun, Ziyong","32324595"],"abstract":["BACKGROUND: The Coronavirus Disease-2019 (COVID-19), infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a severe outbreak in China. The host immunity of COVID-19 patients is unknown. METHODS: The routine laboratory tests and host immunity in COVID-19 patients with different severity of illness were compared after patient admission. RESULTS: A total of 65 SARS-CoV-2-positive patients were classified as mild (n=30), severe (n=20), and extremely severe (n=15) illness. Many routine laboratory tests such as ferritin, lactate dehydrogenase and D-dimer were increased in severe and extremely severe patients. The absolute numbers of CD4+ T cells, CD8+ T cells and B cells were all gradually decreased with increased severity of illness. The activation markers such as HLA-DR and CD45RO expressed on CD4+ and CD8+ T cells were increased in severe and extremely severe patients compared with mild patients. The co-stimulatory molecule CD28 had opposite results. The percentage of natural regulatory T cells was decreased in extremely severe patients. The percentage of IFN-gamma producing CD8+ T cells was increased in both severe and extremely severe patients compared with mild patients. The percentage of IFN-gamma producing CD4+ T cells was increased in extremely severe patients. The IL-2R, IL-6, and IL-10 were all increased in extremely severe patients. The activation of DC and B cells was decreased in extremely severe patients. CONCLUSIONS: The number and function of T cells are inconsistent in COVID-19 patients. The hyperfunction of CD4+ and CD8+ T cells is associated with the pathogenesis of extremely severe SARS-CoV-2 infection."],"journal":"JCI Insight","authors":["Wang, Feng","Hou, Hongyan","Luo, Ying","Tang, Guoxing","Wu, Shiji","Huang, Min","Liu, Weiyong","Zhu, Yaowu","Lin, Qun","Mao, Liyan","Fang, Minghao","Zhang, Huilan","Sun, Ziyong"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32324595","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1172/jci.insight.137799","keywords":["adaptive immunity","cellular immune response","immunology","infectious disease","innate immunity"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493807493120,"score":339.82233},{"pmid":32297828,"title":"Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.","text":["Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.","The aim of this study was to analyze the correlation between dynamic changes in the nasopharyngeal viral load of patients infected with the new coronavirus causing pneumonia and lymphocyte count disease severity. Cases newly diagnosed with COVID-19 at the First Affiliated Hospital of Nanchang University from January 2020 to February 2020 were analyzed retrospectively. Quantitative real-time polymerase chain reaction was used to determine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from throat swab sample DeltaCT values; lymphocyte and lymphocyte subset counts, coagulation system factor levels, myocardial injury indexes, and laboratory biochemical indicators were compared between the mild group and the severe group. The correlation between the relative load of nasopharyngeal SARS-CoV-2 RNA and severe disease symptoms was analyzed. Of the 76 patients, 49 were male and 27 were female. The lymphocyte, CD4(+) T lymphocyte, and CD8(+) T lymphocyte counts all differed significantly between the two groups (p < 0.001), as did differences in interleukin (IL)-2R, IL-6, and IL-8 levels (p = 0.022, 0.026, and 0.012, respectively). Moreover, there were significant differences in prothrombin time, D-dimer, and fibrinogen levels between the mild group and the severe group (p = 0.029, 0.006, and <0.001, respectively), and in lactate dehydrogenase and troponin (p < 0.001 and p = 0.007, respectively). SARS-CoV-2 RNA load and lymphocyte count, CD4(+) T lymphocyte count, and CD8(+) T lymphocyte count were linearly negatively correlated (p < 0.001). SARS-CoV-2 RNA load was positively correlated with IL-2R, prothrombin time, lactate dehydrogenase, and hypersensitive troponin T (p = 0.002, p = 0.009, and p < 0.001, respectively). In addition, the time that it took for the nucleic acid test to turn negative was significantly shorter for patients in the mild group than for those in the severe group (Z = -6.713, p < 0.001). In conclusion, relative SARS-CoV-2 RNA load in the nasopharynx is closely related to COVID-19 severity. If the relative RNA load was higher, the lymphocyte count was lower, organ damage was greater, and the time it took for the nucleic acid test to turn negative was longer.","Viral Immunol","Liu, Yang","Liao, Wenjian","Wan, Lagen","Xiang, Tianxing","Zhang, Wei","32297828"],"abstract":["The aim of this study was to analyze the correlation between dynamic changes in the nasopharyngeal viral load of patients infected with the new coronavirus causing pneumonia and lymphocyte count disease severity. Cases newly diagnosed with COVID-19 at the First Affiliated Hospital of Nanchang University from January 2020 to February 2020 were analyzed retrospectively. Quantitative real-time polymerase chain reaction was used to determine severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from throat swab sample DeltaCT values; lymphocyte and lymphocyte subset counts, coagulation system factor levels, myocardial injury indexes, and laboratory biochemical indicators were compared between the mild group and the severe group. The correlation between the relative load of nasopharyngeal SARS-CoV-2 RNA and severe disease symptoms was analyzed. Of the 76 patients, 49 were male and 27 were female. The lymphocyte, CD4(+) T lymphocyte, and CD8(+) T lymphocyte counts all differed significantly between the two groups (p < 0.001), as did differences in interleukin (IL)-2R, IL-6, and IL-8 levels (p = 0.022, 0.026, and 0.012, respectively). Moreover, there were significant differences in prothrombin time, D-dimer, and fibrinogen levels between the mild group and the severe group (p = 0.029, 0.006, and <0.001, respectively), and in lactate dehydrogenase and troponin (p < 0.001 and p = 0.007, respectively). SARS-CoV-2 RNA load and lymphocyte count, CD4(+) T lymphocyte count, and CD8(+) T lymphocyte count were linearly negatively correlated (p < 0.001). SARS-CoV-2 RNA load was positively correlated with IL-2R, prothrombin time, lactate dehydrogenase, and hypersensitive troponin T (p = 0.002, p = 0.009, and p < 0.001, respectively). In addition, the time that it took for the nucleic acid test to turn negative was significantly shorter for patients in the mild group than for those in the severe group (Z = -6.713, p < 0.001). In conclusion, relative SARS-CoV-2 RNA load in the nasopharynx is closely related to COVID-19 severity. If the relative RNA load was higher, the lymphocyte count was lower, organ damage was greater, and the time it took for the nucleic acid test to turn negative was longer."],"journal":"Viral Immunol","authors":["Liu, Yang","Liao, Wenjian","Wan, Lagen","Xiang, Tianxing","Zhang, Wei"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297828","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1089/vim.2020.0062","keywords":["covid-19","lymphocyte count","nasopharyngeal virus rna load","organ damage"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493245456384,"score":336.7624}]}